Rosenthal Bob
- SEC CIK
- 0001203911
No open-market purchases or sales filed in the past year.
Current role at each company
- BRKR Bruker CorpDirectoras of Feb 18, 2026
- NVIV Invivo Therapeutics Holdings Corp.Directoras of Nov 21, 2022
- SFES Safeguard Scientifics IncDirectoras of Apr 18, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rosenthal Bob as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BRKR Bruker Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 (view filing) | Aug 15 | 1 day | Rosenthal BobDirector | SSale | −4.68K | $63.14 | −$295.7K | −13.1%31.0K after |